Background: Invasive fungal infections (IFI) following allogeneic stem cell transplant (allo-HCT) are associated with high morbidity and mortality. Primary prophylaxis using voriconazole has been shown to decrease the incidence of IFI. Methods: We conducted a retrospective analysis at the Bone Marrow Transplant (BMT) unit of the American University of Beirut including 195 patients who underwent allo-HCT for hematological malignancies and received voriconazole as primary prophylaxis for IFI. The primary endpoints were based on the incidence of IFI at day 100 and day 180, and the secondary endpoint based on fungal-free survival. Results: For the study, 195 patients who underwent allo-HCT between January 2015 and March 2021 were included. The ...
<p>Invasive fungal infections are one of important complication in patients receiving chemotherapy o...
Lung transplant recipients have one of the highest rates of invasive aspergillosis (IA) in solid org...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90237/1/phco.29.11.1306.pd
Background. Recurrence of prior invasive fungal infection (relapse rate of 30-50%) limits the succes...
Background Recurrence of prior invasive fungal infection (relapse rate of 30-50%) limits the success...
AbstractInvasive fungal infections (IFIs) are a major cause of morbidity and mortality in haematopoi...
Patients on systemic glucocorticoids for graft-versus-host disease (GVHD) after hematopoietic cell t...
Seventy-two patients undergoing allogeneic transplantation were treated with voriconazole (VOR) as a...
AbstractInvasive fungal infections (IFIs) are a major cause of morbidity and mortality in haematopoi...
This study has been partially presented as a poster at the 42nd Interscience Conference on Antimicro...
International audienceAlthough the efficacy and safety of voriconazole to treat invasive fungal infe...
In recipients of hematopoietic stem cell transplants (HSCTs), the mortality associated with invasive...
BACKGROUND: Antifungal prophylaxis is a promising strategy for reducing invasive fungal infections (...
Over the past decade, invasive fungal infections (IFI) have remained an important problem in patient...
Voriconazole is frequently discontinued prematurely as primary antifungal prophylaxis (AFP) in allog...
<p>Invasive fungal infections are one of important complication in patients receiving chemotherapy o...
Lung transplant recipients have one of the highest rates of invasive aspergillosis (IA) in solid org...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90237/1/phco.29.11.1306.pd
Background. Recurrence of prior invasive fungal infection (relapse rate of 30-50%) limits the succes...
Background Recurrence of prior invasive fungal infection (relapse rate of 30-50%) limits the success...
AbstractInvasive fungal infections (IFIs) are a major cause of morbidity and mortality in haematopoi...
Patients on systemic glucocorticoids for graft-versus-host disease (GVHD) after hematopoietic cell t...
Seventy-two patients undergoing allogeneic transplantation were treated with voriconazole (VOR) as a...
AbstractInvasive fungal infections (IFIs) are a major cause of morbidity and mortality in haematopoi...
This study has been partially presented as a poster at the 42nd Interscience Conference on Antimicro...
International audienceAlthough the efficacy and safety of voriconazole to treat invasive fungal infe...
In recipients of hematopoietic stem cell transplants (HSCTs), the mortality associated with invasive...
BACKGROUND: Antifungal prophylaxis is a promising strategy for reducing invasive fungal infections (...
Over the past decade, invasive fungal infections (IFI) have remained an important problem in patient...
Voriconazole is frequently discontinued prematurely as primary antifungal prophylaxis (AFP) in allog...
<p>Invasive fungal infections are one of important complication in patients receiving chemotherapy o...
Lung transplant recipients have one of the highest rates of invasive aspergillosis (IA) in solid org...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90237/1/phco.29.11.1306.pd